Identification and functional validation of rad23b as a potential protein in human breast cancer progression

Journal of Proteome Research

Volumn 13, Issue 7, 2014, Pages 3212-3222

  Linge, Annett ^a,b,c   Maurya, Priyanka ^a   Friedrich, Katrin ^b   Baretton, Gustavo B ^b   Kelly, Shane ^a   Henry, Michael ^a   Clynes, Martin ^a   Larkin, Annemarie ^a   Meleady, Paula ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biomarker; breast cancer; invasion; label free LC MS proteomics; RAD23B

Indexed keywords

PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UV EXCISION REPAIR PROTEIN RAD23 HOMOLOGUE B; DNA BINDING PROTEIN; ESTROGEN RECEPTOR; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD23B PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GRADING; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MITOSIS RATE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STAINING; TANDEM MASS SPECTROMETRY; TUMOR INVASION; UPREGULATION; BREAST TUMOR; CARCINOMA, DUCTAL, BREAST; DISEASE COURSE; FEMALE; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DISEASE PROGRESSION; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; RECEPTORS, ESTROGEN; TANDEM MASS SPECTROMETRY;

EID: 84903723277     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4012156     Document Type: Article

References (55)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010 Ca-Cancer J. Clin. 2010, 60, 277-300
2. Alldridge, L.; Metodieva, G.; Greenwood, C.; Al-Janabi, K.; Thwaites, L.; Sauven, P.; Metodiev, M. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry J. Proteome Res. 2008, 7, 1458-1469
3. Bouchal, P.; Roumeliotis, T.; Hrstka, R.; Nenutil, R.; Vojtesek, B.; Garbis, S. D. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis J. Proteome Res. 2009, 8, 362-373
4. Othman, M. I.; Majid, M. I.; Singh, M.; Man, C. N.; Lay-Harn, G. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues Ann. Clin. Biochem. 2008, 45, 299-306
5. Rower, C.; Vissers, J. P.; Koy, C.; Kipping, M.; Hecker, M.; Reimer, T.; Gerber, B.; Thiesen, H. J.; Glocker, M. O. Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue Anal. Bioanal. Chem. 2009, 395, 2443-2456
6. Liu, N. Q.; Dekker, L. J.; Stingl, C.; Guzel, C.; De Marchi, T.; Martens, J. W.; Foekens, J. A.; Luider, T. M.; Umar, A. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches J. Proteome Res. 2013, 12, 4627-4641
7. Mbeunkui, F.; Metge, B. J.; Shevde, L. A.; Pannell, L. K. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer J. Proteome Res. 2007, 6, 2993-3002
8. Leth-Larsen, R.; Lund, R.; Hansen, H. V.; Laenkholm, A. V.; Tarin, D.; Jensen, O. N.; Ditzel, H. J. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry Mol. Cell. Proteomics 2009, 8, 1436-1449
9. Kreunin, P.; Yoo, C.; Urquidi, V.; Lubman, D. M.; Goodison, S. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model Proteomics 2007, 7, 299-312
10. Ho, J.; Kong, J. W.; Choong, L. Y.; Loh, M. C.; Toy, W.; Chong, P. K.; Wong, C. H.; Wong, C. Y.; Shah, N.; Lim, Y. P. Novel breast cancer metastasis-associated proteins J. Proteome Res. 2009, 8, 583-594
11. Lau, T. Y.; Power, K. A.; Dijon, S.; de Gardelle, I.; McDonnell, S.; Duffy, M. J.; Pennington, S. R.; Gallagher, W. M. Prioritization of candidate protein biomarkers from an in vitro model system of breast tumor progression toward clinical verification J. Proteome Res. 2010, 9, 1450-1459
12. Xu, S. G.; Yan, P. J.; Shao, Z. M. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis J. Cancer Res. Clin. Oncol. 2010, 136, 1545-1556
13. Nagaraja, G. M.; Othman, M.; Fox, B. P.; Alsaber, R.; Pellegrino, C. M.; Zeng, Y.; Khanna, R.; Tamburini, P.; Swaroop, A.; Kandpal, R. P. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics Oncogene 2006, 25, 2328-2338
14. Lai, T. C.; Chou, H. C.; Chen, Y. W.; Lee, T. R.; Chan, H. T.; Shen, H. H.; Lee, W. T.; Lin, S. T.; Lu, Y. C.; Wu, C. L.; Chan, H. L. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis J. Proteome Res. 2010, 9, 1302-1322
15. Imai, K.; Ichibangase, T.; Saitoh, R.; Hoshikawa, Y. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry Biomed. Chromatogr. 2008, 22, 1304-1314
16. Paulovich, A. G.; Whiteaker, J. R.; Hoofnagle, A. N.; Wang, P. The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline Proteomics: Clin. Appl. 2008, 2, 1386-1402
17. Watkins, J. F.; Sung, P.; Prakash, L.; Prakash, S. The Saccharomyces cerevisiae DNA repair gene RAD23 encodes a nuclear protein containing a ubiquitin-like domain required for biological function Mol. Cell. Biol. 1993, 13, 7757-7765
18. Schauber, C.; Chen, L.; Tongaonkar, P.; Vega, I.; Lambertson, D.; Potts, W.; Madura, K. Rad23 links DNA repair to the ubiquitin/proteasome pathway Nature 1998, 391, 715-718
19. Perez-Mayoral, J.; Pacheco-Torres, A. L.; Morales, L.; Acosta-Rodriguez, H.; Matta, J. L.; Dutil, J. Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican women Mol. Carcinog. 2013, 52, 127-138
20. Chen, L.; Madura, K. Evidence for distinct functions for human DNA repair factors hHR23A and hHR23B FEBS Lett. 2006, 580, 3401-3408
21. Meleady, P.; Gallagher, M.; Clarke, C.; Henry, M.; Sanchez, N.; Barron, N.; Clynes, M. Impact of miR-7 over-expression on the proteome of Chinese hamster ovary cells J. Biotechnol. 2012, 160, 251-262
22. Meleady, P.; Henry, M.; Gammell, P.; Doolan, P.; Sinacore, M.; Melville, M.; Francullo, L.; Leonard, M.; Charlebois, T.; Clynes, M. Proteomic profiling of CHO cells with enhanced rhBMP-2 productivity following co-expression of PACEsol Proteomics 2008, 8, 2611-2624
23. Weil, D.; Garcon, L.; Harper, M.; Dumenil, D.; Dautry, F.; Kress, M. Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells BioTechniques 2002, 33, 1244-1248
24. Albini, A.; Iwamoto, Y.; Kleinman, H. K.; Martin, G. R.; Aaronson, S. A.; Kozlowski, J. M.; McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res. 1987, 47, 3239-3245
25. Linge, A.; Kennedy, S.; OFlynn, D.; Beatty, S.; Moriarty, P.; Henry, M.; Clynes, M.; Larkin, A.; Meleady, P. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did not Invest. Ophthalmol. Visual Sci. 2012, 53, 4634-4643
26. Humphries, M. J. Cell adhesion assays Methods Mol. Biol. 2000, 139, 279-285
27. Hague, A.; Jones, G. E. Cell motility assays Cell Biol. Toxicol. 2008, 24, 381-389
28. Elston, C. W.; Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 1991, 19, 403-410
29. Clarke, R.; Dickson, R. B.; Brunner, N. The process of malignant progression in human breast cancer Ann. Oncol 1990, 1, 401-407
30. Tong, D.; Czerwenka, K.; Sedlak, J.; Schneeberger, C.; Schiebel, I.; Concin, N.; Leodolter, S.; Zeillinger, R. Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines Breast Cancer Res. Treat. 1999, 56, 91-97
31. Mackinder, M. A.; Evans, C. A.; Chowdry, J.; Staton, C. A.; Corfe, B. M. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis Cancer Biomarkers 2012, 12, 49-64
32. Pilat, M. J.; Christman, J. K.; Brooks, S. C. Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6 Breast Cancer Res. Treat. 1996, 37, 253-266
33. Iyer, S. V.; Dange, P. P.; Alam, H.; Sawant, S. S.; Ingle, A. D.; Borges, A. M.; Shirsat, N. V.; Dalal, S. N.; Vaidya, M. M. Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines PLoS One 2013, 8, e53532
34. dos Santos, P. B.; Zanetti, J. S.; Ribeiro-Silva, A.; Beltrao, E. I. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study Diagn. Pathol. 2012, 7, 104
35. Herrera-Gayol, A.; Jothy, S. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness Exp. Mol. Pathol. 1999, 66, 99-108
36. Renz, M.; Betz, B.; Niederacher, D.; Bender, H. G.; Langowski, J. Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG Int. J. Cancer 2008, 122, 1476-1482
37. Srivastava, M.; Bubendorf, L.; Nolan, L.; Glasman, M.; Leighton, X.; Miller, G.; Fehrle, W.; Raffeld, M.; Eidelman, O.; Kallioniemi, O. P.; Srivastava, S.; Pollard, H. B. ANX7 as a bio-marker in prostate and breast cancer progression Dis. Markers 2001, 17, 115-120
38. Lefrancois-Martinez, A. M.; Bertherat, J.; Val, P.; Tournaire, C.; Gallo-Payet, N.; Hyndman, D.; Veyssiere, G.; Bertagna, X.; Jean, C.; Martinez, A. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors J. Clin. Endocrinol. Metab. 2004, 89, 3010-3019
39. Jiang, X.; Yue, J.; Lu, H.; Campbell, N.; Yang, Q.; Lan, S.; Haffty, B. G.; Yuan, C.; Shen, Z. Inhibition of filamin-A reduces cancer metastatic potential Int. J. Biol. Sci. 2013, 9, 67-77
40. Friedberg, E. C. How nucleotide excision repair protects against cancer Nat. Rev. Cancer 2001, 1, 22-33
41. Katiyar, S.; Lennarz, W. J. Studies on the intracellular localization of hHR23B Biochem. Biophys. Res. Commun. 2005, 337, 1296-1300
42. Davis, J. D.; Lin, S. Y. DNA damage and breast cancer World J. Clin. Oncol. 2011, 2, 329-338
43. Stratton, M. R.; Campbell, P. J.; Futreal, P. A. The cancer genome Nature 2009, 458, 719-724
44. Medicherla, B.; Kostova, Z.; Schaefer, A.; Wolf, D. H. A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation EMBO Rep. 2004, 5, 692-697
45. Ortolan, T. G.; Tongaonkar, P.; Lambertson, D.; Chen, L.; Schauber, C.; Madura, K. The DNA repair protein rad23 is a negative regulator of multi-ubiquitin chain assembly Nat. Cell Biol. 2000, 2, 601-608
46. Shen, Y. H.; Chen, B. R.; Cherng, S. H.; Chueh, P. J.; Tan, X.; Lin, Y. W.; Lin, J. C.; Chuang, S. M. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells Toxicol. Lett. 2011, 205, 341-350
47. Staresincic, L.; Fagbemi, A. F.; Enzlin, J. H.; Gourdin, A. M.; Wijgers, N.; Dunand-Sauthier, I.; Giglia-Mari, G.; Clarkson, S. G.; Vermeulen, W.; Scharer, O. D. Coordination of dual incision and repair synthesis in human nucleotide excision repair EMBO J. 2009, 28, 1111-1120
48. Salisbury, J. L.; Baron, A.; Surek, B.; Melkonian, M. Striated flagellar roots: isolation and partial characterization of a calcium-modulated contractile organelle J. Cell Biol. 1984, 99, 962-970
49. Middendorp, S.; Paoletti, A.; Schiebel, E.; Bornens, M. Identification of a new mammalian centrin gene, more closely related to Saccharomyces cerevisiae CDC31 gene Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 9141-9146
50. Salisbury, J. L.; Suino, K. M.; Busby, R.; Springett, M. Centrin-2 is required for centriole duplication in mammalian cells Curr. Biol. 2002, 12, 1287-1292
51. Araki, M.; Masutani, C.; Takemura, M.; Uchida, A.; Sugasawa, K.; Kondoh, J.; Ohkuma, Y.; Hanaoka, F. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair J. Biol. Chem. 2001, 276, 18665-18672
52. Egeblad, M.; Nakasone, E. S.; Werb, Z. Tumors as organs: complex tissues that interface with the entire organism Dev. Cell 2010, 18, 884-901
53. Nguyen-Ngoc, K. V.; Cheung, K. J.; Brenot, A.; Shamir, E. R.; Gray, R. S.; Hines, W. C.; Yaswen, P.; Werb, Z.; Ewald, A. J. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium Proc. Natl. Acad. Sci. U.S.A. 2012, 109, E2595-E2604
54. Li, D. M.; Feng, Y. M. Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets Breast Cancer Res. Treat. 2011, 128, 7-21
55. Polyak, K. Heterogeneity in breast cancer J. Clin. Invest. 2011, 121, 3786-3788-3788